Amaç: Kuru göz semptomları olan hastalarda, fluoresein gözyaşı kırılma zamanı ile noninvaziv gözyaşı kırılma zamanı (NIGKZ)nın karşılaştırılması amaçlanmıştır. Gereç ve Yöntemler: Çalışmaya kuru göz semptomları olan 200 hasta dâhil edildi. Tüm olgulara ayrıntılı oftalmik muayene yapıldıktan sonra Scheimpflug topografi (CSO Sirius topografi, İtalya) cihazı ile NI-GKZ ölçümü yapıldı. Ardından fluoresein kırılma zamanı ölçümü yapılarak, elde edilen veriler kaydedildi. Tüm gözlere Schirmer testi yapıldı ve oküler yüzey boyanma skorlarına bakıldı. Bulgular: Çalışmaya, 59 erkek 141 kadın hasta dâhil edildi. Çalışmaya alınan hastaların yaş ortalaması 32,71±12,28 (yıl) idi. Fluoresein kırılma zamanı ortalaması, 4,14±3,84 sn olarak saptandı. Topografik olarak gözyaşı filminin ilk kırıldığı zaman 4,32±2,75 sn, son kırıldığı zaman ise 10,6±4,01 sn ve tüm gözyaşı filmi kırılmalarının ortalaması ise 7,37±3,10 sn olarak saptandı. Fluoresein kırılma zamanı ve gözyaşının topografik ölçümde ilk kırıldığı zamanı arasında istatistiksel olarak anlamlı bir fark olmadığı saptandı (p=0,114). Sonuç: Gözyaşı film tabakasının kırılmasını ölçebilen kornea topografi cihazları, gözyaşı film tabakasının değerlendirilmesinde konvansiyonel yöntemlere alternatif olabilir. Kornea topografi cihazları ile yapılan gözyaşı kırılma zamanı ölçümünün invaziv olmaması ve aynı zamanda gözyaşı film tabakasının kırılma haritasını dokümente etmesi konvansiyonel yöntemlere avantajları olarak sayılabilir.
Anahtar Kelimeler: Kuru göz sendromu; gözyaşı film tabakası; gözyaşı kırılma zamanı; kornea topografisi; Scheimpflug kamera
Objective: We aimed to compare fluorescein tear break-up time with non-invasive tear break-up time (NI-BUT) in patients who have dry eye symptoms. Material and Methods: 200 patients with dry eye symptoms were included in the study. After detailed ophthalmic examination, non-invasive tear break up time. measurements performed by Scheimpflug topography device (Sirius topographer, CSO, İtaly) and fluorescein tear film break up time measurements were recorded. Schirmer test and ocular surface staining scores were applied to all eyes. Results: 59 male and 141 female patients were included in this study. The average age of the patients was 32.71±12.28 (year). Fluorescein break-up time of the patient population was 4.14±3.84 seconds on average. Topographically, mean first tear film break-up time was 4.32±2.75 seconds,mean last tear film break-up time was 10.6±4.01 seconds and the average tear film breakup time was 7.37±3.10 seconds. A statistically significant difference was not found between fluorescein break-up time and first non-invasive break up time. (p=0.114). Conclusion: Corneal topography devices which can measure tear film breaking can be an alternative to conventional methods for evaluating tear film layer. The advantage of measurement by corneal topography is being non-invasive, as well as documenting the refraction map of the tear film layer.
Keywords: Dry eye syndrome; tear film layer; tear break-up time; corneal topography; Schempflug camera
- Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017;15(4):802-12.[Crossref] [PubMed]
- The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):93-107.[Crossref] [PubMed]
- Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994-2005.[Crossref] [PubMed] [PMC]
- Bayar SA, Akova YA. [Current treatment methods of dry eye syndrome]. Journal of Experimental and Clinical Medicine. 2012;29:58-65.[Crossref]
- Ji YW, Lee J, Lee H, Seo KY, Kim EK, Kim TI. Automated measurement of tear film dynamics and lipid layer thickness for assessment of non-sjögren dry eye syndrome with meibomian gland dysfunction. Cornea. 2017;36(2):176-82.[Crossref] [PubMed]
- Turhan SA, Toker E. [The effect of topical cyclosporine treatment on tear meniscus variables and ocular surface staining parameters inpatients with dry eye]. Turkiye Klinikleri J Ophthalmol. 2020;29(3):199-206.[Crossref]
- Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006-49.[Crossref] [PubMed] [PMC]
- VanDerMeid KR, Su SP, Ward KW, Zhang JZ. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests. Invest Ophthalmol Vis Sci. 2012;53(3):1512-8.[Crossref] [PubMed]
- Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47(10):4309-15.[Crossref] [PubMed]
- Nichols KK, Nichols JJ, Zadnik K. Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice. Cornea. 2000;19(4):477-82.[Crossref] [PubMed]
- Downie LE, Keller PR. A pragmatic approach to dry eye diagnosis: evidence into practice. Optom Vis Sci. 2015;92(12):1189-97.[Crossref] [PubMed]
- Patel S, Murray D, McKenzie A, Shearer DS, McGrath BD. Effects of fluorescein on tear breakup time and on tear thinning time. Am J Optom Physiol Opt. 1985;62(3):188-90.[Crossref] [PubMed]
- Lamble JW, Gilbert D, Ashford JJ. The break-up time of artificial pre-ocular films on the rabbit cornea. J Pharm Pharmacol. 1976;28(5):450-1.[Crossref] [PubMed]
- McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105(6):1114-9.[Crossref] [PubMed]
- Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110(6):1096-101.[Crossref] [PubMed]
- Szalai E, Berta A, Szekanecz Z, Szûcs G, Módis L Jr. Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system. Cornea. 2012;31(8):867-71.[Crossref] [PubMed]
- Lemp MA, Bron AJ, Baudouin C, Benítez Del Castillo JM, Geffen D, Tauber J, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151(5):792-8.e1.[Crossref] [PubMed]
- Baudouin C, Cochener B, Pisella PJ, Girard B, Pouliquen P, Cooper H, et al. Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease. Eur J Ophthalmol. 2012;22(5):751-61.[Crossref] [PubMed]
- Ozulken K, Aksoy Aydemir G, Tekin K, Mumcuoğlu T. Correlation of non-invasive tear break-up time with tear osmolarity and other invasive tear function tests. Semin Ophthalmol. 2020;35(1):78-85.[Crossref] [PubMed]
- Long Q, Wang JY, Xu D, Li Y. Comparison of corneal biomechanics in Sjögren's syndrome and non-Sjögren's syndrome dry eyes by Scheimpflug based device. Int J Ophthalmol. 2017;10(5):711-6.[PubMed] [PMC]
- Amparo F, Jin Y, Hamrah P, Schaumberg DA, Dana R. What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? Am J Ophthalmol. 2014;157(1):69-77.e2.[Crossref] [PubMed] [PMC]
.: İşlem Listesi